The CING Bioinformatics Group presented PoCCardio and how it supports personalised medicine for heart patients through the use of AI
The clinical, biochemical and genetic data generated in the PoCCardio clinical trial are used to develop a computational AI-based tool for predicting the risk of a heart attack and therapy response in patients.
PoCCardio is funded by the European Union’s Horizon Europe Framework Programme for Research and Innovation under Grant Agreement no. 101095432
© Copyright 2023 – | The PoCCardio Project | All Rights Reserved